Rina Ando

Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

David Adams, Michael Polydefkis, Alejandra González‐Duarte et al. · The Lancet Neurology · 2020 · 154 citations · Full text

Alzheimer's Disease, Open-label Extension Study, Medicine +5

Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions

Masahiro Okada, Taro Shimono, Yoshihiro Komeya et al. · Annals of Nuclear Medicine · 2009 · 73 citations

Positron Emission Tomography, Adrenal Gland, Medical Imaging +11

One year safety and efficacy of inosine to increase the serum urate level for patients with Parkinson's disease in Japan

Hirotaka Iwaki, Rina Ando, Noriyuki Miyaue et al. · Journal of the Neurological Sciences · 2017 · 25 citations

Urological Research, Urology, Medicine +5

A double-blind, randomized controlled trial of duloxetine for pain in Parkinson's disease

Hirotaka Iwaki, Rina Ando, Satoshi Tada et al. · Journal of the Neurological Sciences · 2020 · 23 citations

Pain Therapy, Interventional Pain Medicine, Health Sciences +11

Insomnia and depressive behavior of MyD88-deficient mice: Relationships with altered microglial functions

Mohammed E. Choudhury, Kanta Mikami, Yuiko Nakanishi et al. · Journal of Neuroimmunology · 2021 · 21 citations

Sleep, Psychoneuroimmunology, Psychiatry +12